<DOC>
	<DOCNO>NCT00004381</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy preventive vs. therapeutic tin mesoporphyrin direct Coombs ' test-positive ABO hemolytic disease newborn glucose-6-phosphate dehydrogenase deficiency infant live Greece . II . Assess safety tin mesoporphyrin high-risk newborn .</brief_summary>
	<brief_title>Phase II Randomized Study Tin Mesoporphyrin Neonatal Hyperbilirubinemia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients stratify gestational age sex , randomly assign pair per stratum . One group receive preventive dose tin mesoporphyrin . Another group receive therapeutic dose tin mesoporphyrin accord plasma bilirubin concentration . Patients either group may treat concurrently phototherapy exchange transfusion clinically indicate .</detailed_description>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Hyperbilirubinemia</mesh_term>
	<mesh_term>Erythroblastosis , Fetal</mesh_term>
	<mesh_term>Glucosephosphate Dehydrogenase Deficiency</mesh_term>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Hyperbilirubinemia associate either follow : Direct Coombs ' testpositive ABO hemolytic disease newborn Glucose6phosphate dehydrogenase deficiency Prior/Concurrent Therapy No maternal phenobarbital last month pregnancy Patient Characteristics Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : No congenital renal abnormality Cardiovascular : No congenital heart abnormality Pulmonary : No asphyxia require assist ventilation delivery Other : Gestational age 210 day Birth weight least 1500 g No major congenital abnormality , i.e . : Central nervous system Chromosomal Gastrointestinal No evident suspect congenital infection , e.g . : Cytomegalovirus Herpes Rubella Syphilis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>glucose-6-phosphate dehydrogenase deficiency</keyword>
	<keyword>hematologic disorder</keyword>
	<keyword>hemolytic disease</keyword>
	<keyword>hyperbilirubinemia</keyword>
	<keyword>neonatal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>